[9] In 2021, like in the previous year, CHUV has been ranked as the 9th best hospital in the world by Newsweek Magazine.

On 28 October 2014, the World Health Organization welcomed approval by the Swiss Agency for Therapeutic Products of a vaccine trial against Ebola virus at the University Hospital of Lausanne.

[15] The CHUV is part of the 'Lausanne Integrative Metabolism and Nutrition Alliance', a joint research initiative aiming to promote research and education on metabolism, nutrition, ageing and all associated diseases, such as obesity, diabetes or cancer, in Lausanne area.

[16] The University Hospital of Lausanne publish In vivo, a free magazine aimed at a large audience (general public).

It is produced by the Swiss media agency Large Network and published in French and English.